Navigation Links
Genitourinary in Medical News

Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting

... Annual Meeting in Orlando, Fla. Oral Abstract Session: genitourinary (Prostate) Cancer Abstract Title: "Antitumor Activity of ... principal investigator, chief of the genitourinary Oncology Service and the D. Wayne Calloway ...

Drug shows activity in men with advanced prostate cancer

... who received the drug at higher doses were recently reported at the ASCO genitourinary Cancers Symposium in February 2009 (see abstract: ... encouraging," said Howard Scher, MD, a study co-author and Chief of the genitourinary Oncology Service at MSKCC. "I am looking forward to continuing the study ...

New Prostate Cancer Drug May Hold Promise

... those androgens on the tumor cells, said Dr. Howard I. Scher, chief of the genitourinary oncology service at Memorial Sloan-Kettering Cancer Center in New York ... cancer . SOURCES: Howard I. Scher, M.D., chief, genitourinary oncology service, Memorial Sloan-Kettering Cancer Center, New York City; ...

Tests Might Diagnose, Predict Prostate Cancer

... developing the disease. Both studies were presented Tuesday at the 2009 genitourinary Cancers Symposium in Orlando, Fla., sponsored by the American Society of ... Memorial Sloan-Kettering Cancer Center, New York City; presentations, 2009 genitourinary Cancers Symposium sponsored by American Society of Clinical Oncology, ...

Hormone Therapy Only Helps Some Older Men With Prostate Cancer

... on the gentleman's health," said Dr. Anthony V. D'Amico, chief of genitourinary oncology at Brigham and Women's Hospital in Boston. His report is ... SOURCES: Anthony V. D'Amico, M.D., chief, genitourinary oncology, Brigham and Women's Hospital, Boston; Durado Brooks, director, ...

Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients

... said lead researcher Dr. Anthony V. D'Amico, chief of the division of genitourinary radiation oncology at Brigham & Women's Hospital and the Dana-Farber ... SOURCES: Anthony V. D'Amico, M.D., Ph.D., chief, division of genitourinary radiation oncology, Brigham & Women's Hospital and Dana-Farber Cancer ...

PSA Testing Still Valuable for Prostate Cancer

... treatment for prostate cancer, said Slovin, an assistant member of the genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center, and an ... for the National Prostate Cancer Coalition, an assistant member of the genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center, and an ...

Blood transfusion study: Less is more

... percent, and blood use among men varied from about 50 percent to 100 percent. Transfusions with donor blood were associated with infections of the genitourinary system, respiratory tract, bloodstream, digestive tract and skin, the study said. The risk of death in the hospital was nearly 5 times greater ...

Combination Therapy Best for Aggressive Prostate Cancer

... supporting this treatment method alone based on survival data from randomized trials is lacking," lead researcher Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston, said in a news release from the hospital. "In order to get the highest cure rate for ...

MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009

... than 43,000 cancer treaters globally and covers all major and smaller oncology areas, including lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, hematological malignancies, and melanoma. MDOUTLOOK is being launched in other complex diseases, such as Rheumatoid ...

More>>

Genitourinary in Medical Technology

Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer

... Clinic Taussig Cancer Institute, in a poster discussion during the genitourinary Cancer session. The study enrolled a total of 50 patients, of which ... Principal Investigator Nicholas Vogelzang, MD, Professor and Head of the genitourinary Cancer Program at the Nevada Cancer Institute, stated, "perifosine ...

Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer

... - Data presented today at American Society of Clinical Oncology (ASCO) genitourinary Cancers Symposium - MALVERN, Pa., Feb. 27 /PRNewswire/ -- Ascenta ... prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) genitourinary Cancers Symposium in Orlando, FL. AT-101, an oral, pan-Bcl-2 inhibitor ...

Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients

... - Poster Presented at ASCO genitourinary Cancers Satellite Symposium - SOUTH SAN FRANCISCO, Calif., Feb. 15 ... 1 study of picoplatin, the Company's lead product candidate, at the 2008 genitourinary (GU) Cancers Symposium, a meeting of the American Society of Clinical ...

Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival

... Presented at American Society of Clinical Oncology's genitourinary Symposium - SEATTLE and SAN FRANCISCO, Feb. 14 /PRNewswire-FirstCall/ ... is being presented at the American Society of Clinical Oncology's 2008 genitourinary Symposium in San Francisco. In two Phase 3 trials, D9901 and D9902A, ...

Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

... on average a year or less -- with no approved treatment options," said Howard Scher, M.D., principal investigator of the trial and chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York. "These findings suggest ...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

... with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC) during the American Society of Clinical Oncology (ASCO) 2009 genitourinary Cancers Symposium. Efficacy results to date showed reductions in prostate specific antigen (PSA) levels of at least 50 percent were achieved in 78 ...

Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting

... MDV3100 in patients (pts) with progressive Castration-Resistant Prostate Cancer (CRPC)" by principal investigator, Howard Scher, M.D., chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York. The ongoing Phase 1-2 ...

US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings

... of gemcitabine/oxaliplatin versus paclitaxel/carboplatin as first-line therapy for advanced non-small cell lung cancer (NSCLC) genitourinary -- Guru Sonpavde, M.D., Texas Oncology-Deke Slayton Cancer Center: Phase II study of Azacitidine for castration-resistant prostate cancer ...

Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting

... in Patients with Progressive Castration-Resistant Prostate Cancer (CRPC)" (Abstract #5006) To be presented by: Howard Scher, M.D., chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York, at approximately 12:15 ...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

... immunotherapy for prostate cancer and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC)" (Abstract #5146, genitourinary Cancer Session) -- Poster presentation from 8:00 a.m. to 12:00 p.m. local time on Saturday, May 31, 2008. Clinical and Preclinical Data of ...
Genitourinary in Medical Dictionary

Genitourinary system

... Trauma of the genitourinary system is defined as injury resulting from ... those concerned with reproduction. Also called genitourinary system , urogenital system, or urogenital ... parts of the esophagus and trachea ), and the genitourinary system . ...

Genital

... warts are the most common sexually transmitted infection diagnose d in genitourinary medicine (GUM) clinics. We look at the best ways to prevent infection , ... excretion of urine and those concerned with reproduction. Also called genitourinary system , uro genital system, or uro genital tract. Genital ...

Genital warts

... warts are the most common sexually transmitted infection diagnose d in genitourinary medicine (GUM) clinics. We look at the best ways to prevent infection , ... excretion of urine and those concerned with reproduction. Also called genitourinary system , urogenital system, or urogenital tract. Genital Warts ...

Gland

... s T3 and T4. Common causes include an enlarged prostate gland in older men, sagging pelvic muscle s in older women, and tumor s in the genitourinary organ s of both males and females. Plenaxis (abarelix depot) A peptide antagonist that inhibits the action of gonad otropin-releasing hormone ...

Intestinal obstruction

... stress with or without hepatomegaly or cord compress ion and neurologic deficit or inferior vena cava compress ion and renal ischemia ; or genitourinary obstruction; or gastrointestinal obstruction and ... Fever and headache are other constitutional symptoms. Severe involvement of the rectal ...

Invasive

... any and all treatment options with your healthcare professional. Minimally Invasive Surgical Procedures used to correct disorders of the genitourinary System Programs that treat this condition Center for Bladder Exstrophy Care & Support Group ... Arthroscopy : Less invasive surgery for ...

Ischemia

... pressure point. Such symptoms include respiratory di stress , renal or bowel ischemia , spinal cord compress ion, gastrointestinal or genitourinary obstruction, or coagulopathy. bowel angina , or pain in the abdomen which is worse after meals, or bowel ischemia (decreased blood ...

Nephropathy

... may result in kidney damage. Also called nephropathy . Large birth weight ... [25] Patients with Wilms' tumor and aniridia without genitourinary abnormalities are at lesser risk but should be monitored for nephropathy or renal failure. it is a useful ' first -line treatment for ...

Prostate

... and lung cancer . Common causes include an enlarged prostate gland in older men, sagging pelvic muscle s in older women, and tumor s in the genitourinary organ s of both males and females. Prognosis The projected outcome of a disease ; the life expectancy. PSA ( Prostate -specific antigen ) A ...

Soy

... in abundance), nuts and seeds. An isoflavone found in soy products. Soy isoflavones are being studied to see if they help prevent cancer . genitourinary system (GEN-ih-toe-YOO-rin-air-ee) ... A natural approach to treatment includes taking natural plant oestrogens - called phytoestrogens or ...

More>>

Genitourinary in Biological News

Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test

... K. Oh, M.D., clinical director, Lank Center for genitourinary Oncology, DFCI today presented the data from ... at the American Society for Clinical Oncology's genitourinary Cancers Symposium. The study was co-investigated ... Ross, M.D., attending physician, Lank Center for genitourinary Oncology, DFCI. The PCCTC, a national clinical ...

New drug shows promise in treating drug-resistant prostate cancer

... what Jung described as "the pivotal Phase 3 clinical trials." The results of clinical studies with MDV3100 were described at the 2009 ASCO genitourinary Cancer Symposium in February by the trials' principal investigator, Dr. Howard Scher of Memorial Sloan-Kettering Cancer Center. In general, the drug, ...

UF scientist tapped by Howard Hughes Medical Institute to pursue 'best ideas'

... cellular processes that take place in external genitalia development, like outgrowth and closure of the urethral tube," Cohn said. "The incidence of genitourinary malformations in humans came as a huge surprise to me. A staggeringly high frequency of one in 250 kids has a urethral tube defect, and that number ...

UCLA/VA partners with ASU to advance biosensor technology for urinary tract infections

... have pioneered treatments for many conditions, including cancers of the prostate, bladder and kidney; kidney stones; pelvic floor disorders; genitourinary tract conditions; incontinence; and sexual dysfunction in men and women. The Biodesign Institute at Arizona State University is focused on ...

More kidney cancer is detected and treated early, yet death rate rises

... are some patients with small kidney tumors for whom surgery is not the best option." Kidney cancer is the third most common malignancy of the genitourinary system (the reproductive system and urinary system). The American Cancer Society estimates there will be about 38,890 new cases of kidney cancer ...
Genitourinary in Biological Technology

Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

... - - Data To Be Presented at ASCO's 2009 genitourinary Cancers Symposium - - Medivation to Host ... investigator of the trial and chief of the genitourinary Oncology Service and the D. Wayne Calloway Chair ... Society of Clinical Oncology's (ASCO) 2009 genitourinary Cancers Symposium in Orlando, Fla. ...

Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer

... the American Society of Clinical Oncology's 2009 genitourinary Cancers Symposium - SOUTH SAN FRANCISCO, ... M.D., clinical director of the Lank Center for genitourinary Oncology at the Dana Farber Cancer Institute and ... Society of Clinical Oncology's (ASCO) 2009 genitourinary Cancers Symposium in Orlando, Fla. Picoplatin, ...

AEterna Zentaris to Present Data Supporting Evaluation of AEZS-108 in Prostate Cancer at Upcoming ASCO Meeting

... investigation of the drug in hormone-refractory prostate cancer, a major genitourinary cancer indication in male patients. Abstract selected for presentation is as follows: genitourinary Cancer Sunday, May 31, 2009: # 5103: Expression of LHRH receptors ...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

... metastatic castration resistant prostate cancer (mCRPC)" (Abstract #5138, genitourinary Cancer - Prostate Session) S. Slovin - General poster from 2:00 p.m. to ... metastatic castration-resistant prostate cancer (mCRPC)" (Abstract #5144, genitourinary Cancer Session) M. Mohebtash - General poster from 2:00 p.m. to 6:00 p.m. ...

OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer

... Data presented at the 2008 genitourinary Cancers Symposium VANCOUVER, Feb. 15 /PRNewswire/ - OncoGenex ... with chemotherapy alone. Phase 2 data were presented today at the 2008 genitourinary Cancers Symposium. OncoGenex and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ...

AEterna Zentaris Presents Data Supporting Evaluation of AEZS-108 in Prostate Cancer at ASCO Meeting

... prolonged use of LHRH agonists; these data provide further support to the investigation of AEZS-108 in hormone-refractory prostate cancer, a major genitourinary cancer indication in male patients." Results LHRH receptor expression was demonstrated in more than 95% of 130 prostate cancer specimens ...

The Arcas Group Appoints Executive Vice President

... treaters in North America and Europe and covers all major and smaller oncology areas, including lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, hematological malignancies and melanoma. MDOUTLOOK will be launched shortly in other complex diseases, such as Ophthalmology, Parkinson's ...

Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009

... presented at international cancer symposium In February 2009, data on PROSTVAC(TM) were presented at the international cancer congress, 2009 genitourinary Cancers Symposium in Orlando, Florida. The data from three different studies once again confirm the excellent safety and efficacy results previously ...

Bavarian Nordic Publishes its Annual Results 2008

... - further data presented In February 2009, the first detailed data on PROSTVAC(TM) were presented at the international cancer congress, 2009 genitourinary Cancers Symposium in Orlando, Florida. The data from three different studies once again confirms the excellent safety and efficacy results ...

Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update

... trial in patients with castration-resistant prostate cancer (CRPC). Presented data from our Phase 1-2 clinical trial at ASCO's 2009 genitourinary Cancers Symposium showing that MDV3100 consistently demonstrated encouraging anti-tumor activity across dose levels, endpoints and in both pre- and ...
Other Contents
(Date:3/26/2015)... “The SWEET Act is an important step to invigorate ... help parents who are working to reduce sugar in their ... support public health, and we will continue to stand on ... all families,” said Dr. Jane Delgado President and CEO of ... the Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. ...
(Date:3/26/2015)... Greenwod Village, CO (PRWEB) March 26, 2015 ... to providing help where it is most needed but ... Moses supplies therapeutic milk to six clinics in the ... suffering from severe malnutrition. During a recent visit to ... reach out to the mothers and their babies in ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Dr. Alex ... proud to announce expanded offerings for Bay Area patients ... Dental Implant Center has long been a top-rated center, ... its offerings to meet the strong demand by others ... reputation as a top-rated dental implant facility in San ...
(Date:3/26/2015)... Calif. (PRWEB) March 26, 2015 Pacific ... repairs, is pleased to be featured on Innovations with ... on March 18, 2015. The episode will repeat ... is live on the Pacific Medical home page at: ... life threatening emergencies, it is reassuring to trust the ...
(Date:3/26/2015)... BioPlus Specialty Pharmacy ... pharmacies, announces the promotion of Sharon Ferrer to ... Pharmaceutical Relations. In this position, Ferrer will be ... partners and providing key leadership in building and ... , “Over the past seven years that ...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
(Date:3/10/2015)... Utah , March 10, 2015   Tute ... interpretation, has been selected by next-generation sequencing company ... of whole exome and targeted gene panel interpretation. ... provider, has adopted the most current technologies to support ... genetic research. The company offers two types of exome ...
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biometrics Market Forecast and Opportunities, ... The market for biometric authentication systems is projected ... till 2020 The driving forces for ... needs, government projects and constant development in technology. ...
(Date:3/2/2015)... , March 2, 2015  Businesses have a ... protection company Tharon Rankins Enterprises has announced the ... an ultra-safe way for businesses to protect their ... transactions. Beconux is a biometric ... Enterprises. Functioning similarly to an ATM machine, the ...
Breaking Biology News(10 mins):PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Personal Data Protection Company Launches New Product 2
Other TagsOther Tags